Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM).
- 2020-10
- RCT
- Maturitas 140
- Chuleekorn Sritonchai
- Jittima Manonai
- Areepan Sophonsritsuk
- Wichai Cherdshewasart
- PubMed: 32972635
- DOI: 10.1016/j.maturitas.2020.06.005
- High evidence
- Clinical
the proportion of participants with an abnormal Nugent score in the P. mirifica and the placebo groups were 6.7 % (2/30) and 23.3 % (7/30), respectively (p = 0.006)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 5% P. mirifica vaginal gel